• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠合并肺动脉高压及抗凝治疗并发症的病例报告

A case report of pulmonary arterial hypertension in pregnancy and complications of anticoagulation therapy.

作者信息

Xiang Yangfang, Li Jun, Sun Yinxiang

机构信息

Pharmacy Department Cardiovascular Medicine Department, People's Hospital of Zhuhai City, Zhuhai City, China.

出版信息

Medicine (Baltimore). 2018 Aug;97(32):e11810. doi: 10.1097/MD.0000000000011810.

DOI:10.1097/MD.0000000000011810
PMID:30095650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6133479/
Abstract

RATIONALE

Treprostinil, a potent vasodilator, is the treatment of choice for severe pulmonary arterial hypertension (PAH) during pregnancy. Its inhibition of platelet aggregation increases the risk of hemorrhage. In addition, anticoagulation therapy is widely used in pregnancy with PAH due to the hypercoagulable state. However, very little is known about the complications of anticoagulants' use in pregnancy with PAH.

PATIENT CONCERNS

A 27-year-old pregnant woman was admitted to the hospital at 32weeks with progressive dyspnea.

DIAGNOSES

The pregnant was diagnosed with ventricular septal defect 12 years prior to presentation. Combining clinical manifestation with results of right heart catheterization (RHC) and echocardiography, it was consistent with severe World Health Organization (WHO) group I PAH.

INTERVENTIONS

Supportive treatment included supplemental oxygen, intravenous treprostinil, sildenafil and prophylactic anticoagulation.

OUTCOMES

Gastrointestinal bleeding is occurred in our patient when dalteparin were used in conjunction with treprostinil. Her care was further complicated refractory to usual conservative measures before delivery.

LESSONS

This case report illustrates the complexities that arise when prostacyclin therapies are combined with necessary anticoagulation in patients with PAH during pregnancy. More intention should play to the complications of anticoagulant in pregnancy with PAH during treprostinil therapy.

摘要

原理

曲前列尼尔是一种强效血管扩张剂,是孕期重度肺动脉高压(PAH)的首选治疗药物。它抑制血小板聚集会增加出血风险。此外,由于高凝状态,抗凝治疗在PAH孕期广泛应用。然而,对于PAH孕期使用抗凝剂的并发症知之甚少。

患者情况

一名27岁孕妇在孕32周时因进行性呼吸困难入院。

诊断

该孕妇在此次就诊前12年被诊断为室间隔缺损。结合临床表现、右心导管检查(RHC)和超声心动图结果,符合重度世界卫生组织(WHO)I组PAH。

干预措施

支持性治疗包括补充氧气、静脉注射曲前列尼尔、西地那非和预防性抗凝。

结果

当达肝素与曲前列尼尔联合使用时,我们的患者发生了胃肠道出血。在分娩前,她的病情因常规保守措施无效而进一步复杂化。

经验教训

本病例报告说明了孕期PAH患者在使用前列环素疗法并联合必要的抗凝治疗时出现的复杂性。在曲前列尼尔治疗期间,应更加关注PAH孕期使用抗凝剂的并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4427/6133479/b5c8512aa8cf/medi-97-e11810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4427/6133479/2b535bb4e7e2/medi-97-e11810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4427/6133479/b5c8512aa8cf/medi-97-e11810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4427/6133479/2b535bb4e7e2/medi-97-e11810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4427/6133479/b5c8512aa8cf/medi-97-e11810-g002.jpg

相似文献

1
A case report of pulmonary arterial hypertension in pregnancy and complications of anticoagulation therapy.妊娠合并肺动脉高压及抗凝治疗并发症的病例报告
Medicine (Baltimore). 2018 Aug;97(32):e11810. doi: 10.1097/MD.0000000000011810.
2
Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension.重度肺动脉高压妊娠中的抗凝并发症
J Matern Fetal Neonatal Med. 2018 May;31(9):1209-1213. doi: 10.1080/14767058.2017.1312329. Epub 2017 Apr 16.
3
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report.新型纯合子BMP9无义突变导致肺动脉高压:一例报告
BMC Pulm Med. 2016 Jan 22;16:17. doi: 10.1186/s12890-016-0183-7.
4
Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.肺动脉高压患者从皮下注射曲前列尼尔转换为口服西地那非的安全性和有效性。
J Heart Lung Transplant. 2007 Nov;26(11):1079-83. doi: 10.1016/j.healun.2007.07.040. Epub 2007 Oct 24.
5
Treatment of pulmonary arterial hypertension in pregnancy.妊娠期肺动脉高压的治疗
Am J Health Syst Pharm. 2007 Sep 15;64(18):1922-6. doi: 10.2146/ajhp060391.
6
Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.华法林对皮下注射曲前列尼尔的肺动脉高压患者生存的影响。
Cardiovasc Ther. 2017 Oct;35(5). doi: 10.1111/1755-5922.12281.
7
Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.曲前列尼尔在 SU5416 低氧肺动脉高压模型中的疗效:血流动力学获益与动脉重塑的改善无关。
Br J Pharmacol. 2018 Oct;175(20):3976-3989. doi: 10.1111/bph.14472. Epub 2018 Sep 16.
8
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.吸入性曲前列尼尔联合口服药物治疗肺动脉高压的随机对照临床试验。
J Am Coll Cardiol. 2010 May 4;55(18):1915-22. doi: 10.1016/j.jacc.2010.01.027.
9
Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.妊娠合并肺动脉高压:病例系列及标准治疗方法。
Lung. 2012 Apr;190(2):155-60. doi: 10.1007/s00408-011-9345-9. Epub 2011 Dec 3.
10
Cost effectiveness of prostacyclins in pulmonary arterial hypertension.前列腺素类药物治疗肺动脉高压的成本效益。
Appl Health Econ Health Policy. 2012 May 1;10(3):175-88. doi: 10.2165/11630780-000000000-00000.

本文引用的文献

1
[Controversy over anticoagulation in patients with pulmonary arterial].[肺动脉疾病患者抗凝治疗的争议]
Zhonghua Yi Xue Za Zhi. 2018 Jan 9;98(2):81-83. doi: 10.3760/cma.j.issn.0376-2491.2018.02.001.
2
Management of newly diagnosed immune thrombocytopenia: can we change outcomes?新诊断免疫性血小板减少症的管理:我们能否改变治疗结果?
Blood Adv. 2017 Nov 14;1(24):2295-2301. doi: 10.1182/bloodadvances.2017009860.
3
Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.
华法林对皮下注射曲前列尼尔的肺动脉高压患者生存的影响。
Cardiovasc Ther. 2017 Oct;35(5). doi: 10.1111/1755-5922.12281.
4
The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.2015年美国食品药品监督管理局妊娠及哺乳期用药标签规则
J Midwifery Womens Health. 2017 May;62(3):308-316. doi: 10.1111/jmwh.12611. Epub 2017 May 29.
5
Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension.重度肺动脉高压妊娠中的抗凝并发症
J Matern Fetal Neonatal Med. 2018 May;31(9):1209-1213. doi: 10.1080/14767058.2017.1312329. Epub 2017 Apr 16.
6
An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension.一项关于吸入性曲前列尼尔在肺动脉高压患者中呼吸相关安全性的观察性研究。
Pulm Circ. 2016 Sep;6(3):329-37. doi: 10.1086/688059.
7
Gestational pulmonary arterial hypertension.妊娠合并肺动脉高压
Pulm Circ. 2015 Dec;5(4):730-3. doi: 10.1086/683689.
8
[ESC guidelines 2015 on pulmonary hypertension].[2015年欧洲心脏病学会肺动脉高压指南]
Herz. 2015 Dec;40(8):1055-60. doi: 10.1007/s00059-015-4381-5.
9
Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.肺动脉高压患者的抗凝治疗:当前知识的更新。
J Heart Lung Transplant. 2016 Feb;35(2):151-64. doi: 10.1016/j.healun.2015.10.002. Epub 2015 Oct 9.
10
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015 ESC/ERS 肺动脉高压诊断与治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断与治疗工作组制定:该指南得到了欧洲儿科和先天性心脏病协会(AEPC)以及国际心肺移植学会(ISHLT)的认可。
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.